This trial studies the frequency of incident and prevalent of cancer in people living with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) at cancer centers in Latin America. By counting how many people living with HIV/AIDS have cancer at these specific centers, researchers may better understand how they are being treated and cared for. This may help researchers to understand what new studies may be helpful for those areas in the future.
PRIMARY OBJECTIVES: I. To determine the number of diagnosed cancers in people living with HIV/AIDS (PLWHA) presenting to participating clinical sites in Latin America, and estimate site-specific prevalence based on all presenting cancers (new diagnosis, recurrence, and surveillance cases) and site-specific incidence based on newly diagnosed cancers. SECONDARY OBJECTIVES: I. Obtain information on the use of diagnostic testing and treatment for the cohort of diagnosed HIV-associated cancer participants. II. To collect information on participant characteristics for diagnosed HIV-associated cancers (e.g., antiretroviral therapy \[ART\] regimen, current CD4 count, current viral load, etc.). OUTLINE: Patients respond to surveys and/or undergo medical record review at baseline and at 4 weeks.
Correlative studies
Respond to surveys
Buenos Aires, Argentina